Clinical Trials
3 trialsNCT07308106 2026-05-11
A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2 Recruiting
NCT06293690 2025-12-18
Toripalimab Combined With SBRT for NSCLC
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Active not recruiting
NCT07199010 2025-09-30
Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression
Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting